July 23, 2014 4:51 PM ET

Pharmaceuticals

Company Overview of Emmaus Life Sciences, Inc.

Company Overview

Emmaus Life Sciences, Inc. is engaged in the discovery, development, and commercialization of treatments and therapies for rare and orphan diseases. The company’s lead product candidate includes pharmaceutical-grade L-glutamine, which has completed Phase III clinical trials for the treatment of sickle cell disease. It also markets and sells NutreStore, an L-glutamine powder for oral solution as a treatment for short bowel syndrome in patients receiving specialized nutritional support; and sells L-glutamine as a nutritional supplement under the AminoPure brand name through retail stores in various states, as well as through importers and distributors in Japan, Taiwan, and South Korea. The com...

20725 South Western Avenue

Suite 136

Torrance, CA 90501

United States

Founded in 2000

16 Employees

Phone:

310-214-0065

Key Executives for Emmaus Life Sciences, Inc.

Chief Executive Officer
Age: 54
Chief Financial Officer
Age: 59
Chief Operating Officer
Age: 53
Senior Vice President of Finance
Age: 46
Chief Administrative Officer and Corporate Secretary
Age: 38
Compensation as of Fiscal Year 2014.

Emmaus Life Sciences, Inc. Key Developments

Emmaus Life Sciences, Inc. Announces Board Appointments

Emmaus Life Sciences, Inc. announced the appointment of four new members to its Board of Directors: Duane Kurisu, Chairman and CEO of Aio; Moni Miyashita, Senior Advisor with a global consulting firm and former IBM Vice President, Corporate Development; Phillip Satow, Chairman of the Board of JDS Therapeutics and co-Founder and former CEO of JDS Pharmaceuticals; and Mayu Sris, Founding Partner and Managing Director of Sarissa Capital Management. Mr. Kurisu, Ms. Miyashita, Mr. Satow and Mr. Sris join Emmaus' independent directors, Tracey Doi, Chief Financial Officer of Toyota Motor Sales, U.S.A., and Dr. Henry McKinnell, Chairman of the Board of Moody's Corporation and former Chairman and CEO of Pfizer. Ms. Miyashita is an independent advisor on mergers and acquisitions at a global consulting firm. She previously held a more than 30 year career at IBM, where she served as Vice President, Corporate Development. Mr. Satow is currently Chairman of the Board of Directors of JDS Therapeutics, LLC. Mr. Sris is a Founding Partner and Managing Director of Sarissa Capital Management LP. He most recently served as an Investment Analyst at Icahn Capital, 2005 to 2010 and as a consultant in 2011, where he contributed to all aspects of the activist investing process with the goal of proactively creating substantial value.

Emmaus Life Sciences, Inc. announced delayed 10-Q filing

On 05/16/2014, Emmaus Life Sciences, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Emmaus Life Sciences, Inc. Elects Mayuran Sriskandarajah to the Board

Emmaus Life Sciences, Inc. announced that on May 8, 2014, the Board elected Mayuran Sriskandarajah (Mayu Sris or Mr. Sris) to serve as a member of the Board and expanded the size of the Board from six members to seven members. Mr. Sris is a Founding Partner and Managing Director of Sarissa Capital Management LP. He most recently served as an Investment Analyst at Icahn Capital from 2005 to 2010 and as a consultant in 2011, where he contributed to all aspects of the activist investing process with the goal of proactively creating substantial value.

Similar Private Companies By Industry

Company Name Region
Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company United States
Koltman Pharmaceuticals Inc. United States
Wockhardt USA, Inc. United States
Cedarburg Laboratories, Inc. United States
Maret Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
May 12, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Emmaus Life Sciences, Inc., please visit www.emmausmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.